Modafinil

Overview

Modafinil is a wakefulness-promoting agent approved for the treatment of narcolepsy, obstructive sleep apnea, and shift work sleep disorder. It is thought to work by altering the natural chemicals (neurotransmitters) in the brain.

API suppliers (13)

Suppliers of Modafinil evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

• Alembic Pharmaceuticals LimitedIndia1 active DMF GMP on record
• Dipharma Francis SrlItaly1 active DMF GMP on record
• CHROMO LABORATORIES INDIA PRIVATE LTDIndia1 active DMF
• Viyash Scientific LtdIndia1 active DMF GMP on record
• ORBION PHARMACEUTICALS PRIVATE LTDIndia1 active DMF GMP on record
• APITORIA PHARMA PRIVATE LTDIndia1 active DMF GMP on record
• MATRIX PHARMACORP PRIVATE LTDIndia1 active DMF
• TAPI NL BVNetherlands1 active DMF
• WAVELENGTH ENTERPRISES LTDIsrael1 active DMF GMP on record
• Sun Pharmaceutical Industries LimitedIndia GMP on record
• HAS Healthcare Advanced Synthesis SASwitzerland GMP on record
• UNION QUIMICO FARMACEUTICA SA (UQUIFA SA)Spain
• FLAMMA SPAItaly GMP on record

EU CEP holders (9)

Companies holding a valid EU Certificate of Suitability (CEP) for Modafinil, from the EDQM certification database. A CEP holder is a documented EU-market source of the substance — not necessarily the manufacturer — and these are not yet profiled in our directory.

Therapeutic areas